Correlation Analysis of Histopathology and Proteogenomics Data for Breast Cancer*
暂无分享,去创建一个
Kun Huang | Zhi Han | Jie Zhang | Bryan Helm | Xiaohui Zhan | Zhi Huang | Xiaowen Liu | Zhi Han | Jie Zhang | Kun Huang | Jun Cheng | Dong Ni | Bryan R Helm | Xiaowen Liu | Zhi Huang | Dong Ni | Jun Cheng | Tian-Fu Wang | Tianfu Wang | Xiaohui Zhan
[1] K. H. White,et al. Nuclear size regulation: from single cells to development and disease. , 2013, Trends in cell biology.
[2] Michael L. Gatza,et al. Proteogenomics connects somatic mutations to signaling in breast cancer , 2016, Nature.
[3] Andrew H. Beck,et al. Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival , 2011, Science Translational Medicine.
[4] Qianjin Feng,et al. Identification of topological features in renal tumor microenvironment associated with patient survival , 2017, Bioinform..
[5] Peng Qiu,et al. TCGA-Assembler: open-source software for retrieving and processing TCGA data , 2014, Nature Methods.
[6] Qianjin Feng,et al. Integrative Analysis of Histopathological Images and Genomic Data Predicts Clear Cell Renal Cell Carcinoma Prognosis. , 2017, Cancer research.
[7] R. Weinberg,et al. Understanding the tumor immune microenvironment (TIME) for effective therapy , 2018, Nature Medicine.
[8] M. Nowak,et al. Dynamics of cancer progression , 2004, Nature Reviews Cancer.
[9] Mary Goldman,et al. The UCSC Xena platform for public and private cancer genomics data visualization and interpretation , 2018, bioRxiv.
[10] T. Murdoch,et al. The inevitable application of big data to health care. , 2013, JAMA.
[11] H. Moses,et al. Tumor-stroma interactions. , 2005, Current opinion in genetics & development.
[12] L. Emens. Breast Cancer Immunotherapy: Facts and Hopes , 2017, Clinical Cancer Research.
[13] Sidra Nawaz,et al. Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology , 2015, Laboratory Investigation.
[14] Giulio Gabbiani,et al. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. , 2004, The International journal of developmental biology.
[15] T. Hagemann,et al. The tumor microenvironment at a glance , 2012, Journal of Cell Science.
[16] David Gomez-Cabrero,et al. Data integration in the era of omics: current and future challenges , 2014, BMC Systems Biology.
[17] A. Barrientos,et al. Mitochondrial ribosomes in cancer. , 2017, Seminars in cancer biology.
[18] U. Kayisli,et al. Extracellular Matrix-Dependent Regulation of Fas Ligand Expression in Human Endometrial Stromal Cells , 2002, Biology of reproduction.
[19] C. Lindskog,et al. A pathology atlas of the human cancer transcriptome , 2017, Science.
[20] Yuan Ji,et al. TCGA-Assembler 2: Software Pipeline for Retrieval and Processing of TCGA/CPTAC Data , 2017, bioRxiv.
[21] Peter W. Laird,et al. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer , 2018, Cell.
[22] F. Markowetz,et al. Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling , 2012, Science Translational Medicine.
[23] Yinyin Yuan. Spatial Heterogeneity in the Tumor Microenvironment. , 2016, Cold Spring Harbor perspectives in medicine.
[24] M. Dehghani,et al. Review of cancer from perspective of molecular , 2017 .
[25] Jean Qiu,et al. The metabolic demands of cancer cells are coupled to their size and protein synthesis rates , 2013, Cancer & Metabolism.
[26] M. Nykter,et al. Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression , 2018, Nature Communications.
[27] Chao Wang,et al. Identifying survival associated morphological features of triple negative breast cancer using multiple datasets , 2013, Journal of the American Medical Informatics Association : JAMIA.
[28] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[29] Stef van Buuren,et al. MICE: Multivariate Imputation by Chained Equations in R , 2011 .
[30] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[31] K. Pienta,et al. Targeting the tumour stroma to improve cancer therapy , 2018, Nature Reviews Clinical Oncology.
[32] Daoqiang Zhang,et al. Ordinal Multi-modal Feature Selection for Survival Analysis of Early-Stage Renal Cancer , 2018, MICCAI.
[33] C. Lynch. Big data: How do your data grow? , 2008, Nature.
[34] Jing Chen,et al. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..
[35] Raghu Machiraju,et al. Breast cancer patient stratification using a molecular regularized consensus clustering method. , 2014, Methods.
[36] Ø. Borgan,et al. Modeling Survival Data: Extending the Cox Model. Terry M. Therneau and Patricia M. Grambsch, Springer-Verlag, New York, 2000. No. of pages: xiii + 350. Price: $69.95. ISBN 0-387-98784-3 , 2001 .
[37] C. Catoi,et al. TUMOR CELL MORPHOLOGY , 2007 .
[38] Z. Werb,et al. Remodelling the extracellular matrix in development and disease , 2014, Nature Reviews Molecular Cell Biology.
[39] E. Winer,et al. Atezolizumab and Nab‐Paclitaxel in Advanced Triple‐Negative Breast Cancer , 2018, The New England journal of medicine.
[40] Wei Xiong,et al. Role of tumor microenvironment in tumorigenesis , 2017, Journal of Cancer.
[41] R. W. Scarff,et al. THE POSITION OF HISTOLOGY IN THE PROGNOSIS OF CARCINOMA OF THE BREAST. , 1928 .
[42] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[43] R. Gray. Modeling Survival Data: Extending the Cox Model , 2002 .
[44] Allison P. Heath,et al. Toward a Shared Vision for Cancer Genomic Data. , 2016, The New England journal of medicine.
[45] J. Bertram. The molecular biology of cancer. , 2000 .
[46] Jun Kong,et al. Integrated morphologic analysis for the identification and characterization of disease subtypes , 2012, J. Am. Medical Informatics Assoc..
[47] Nicholas P. Tatonetti,et al. Translational medicine in the Age of Big Data , 2017, Briefings Bioinform..
[48] M. Stratton,et al. The cancer genome , 2009, Nature.
[49] Carsten Denkert,et al. Clinical relevance of host immunity in breast cancer: from TILs to the clinic , 2016, Nature Reviews Clinical Oncology.